Clinical trials: Ileal Conduit
Bladder Cancer
A Clinical Trial of Extraperitonealization for Prevention of Parastomal Hernia After Ileal Conduit
Many complications may occur after ileal conduit, with the incidence increasing with time after surgery. Nearly half of the complications are related to stoma and ureteroileal anastomosis.
- Trial name
- NCT03822234
- Testing
- Modified ileal conduit
- Where
- China
- Volunteers
- 104 people
- Sponsor
- Sun Yat-sen University
Ostomy, Ileal Conduit
Ostomy Simulation for Patient Education Prior to Urologic Bowel Diversion Surgeries
The purpose of this study is to evaluate the feasibility of using a realistic and anatomically accurate 3D printed simulation model for urologic bowel diversion patient education.
- Trial name
- NCT06583577
- Testing
- 3D Ostomy simulator
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- University of Minnesota
Urothelial Carcinoma, Cystectomy
Evaluation of Robot-assisted Intracorporeal Urinary Reconstruction
Continous evaluation of clinical and oncologic outcome of robot-assisted cystectomy with intracorporeal reconstruction of urinary diversion. Patient Data is entered in an anonymized registry for analyzation.
- Conditions
- Urothelial Carcinoma, Cystectomy, Urinary Diversion, Complication of Surgical Procedure
- Trial name
- iRARC-KSW (NCT03280459)
- Testing
- robot-assisted cystectomy
- Where
- Switzerland
- Volunteers
- 200 people
- Sponsor
- Kantonsspital Winterthur KSW
Patient Satisfaction, Bladder Cancer
Ileal Conduit Versus Cutaneous Ureterostomy After Radical Cystectomy
Bladder cancer is the most common malignancy of the urinary tract and accounts for about 3.2% of all cancer worldwide where it remains the seventh most commonly diagnosed malignancy in the male population.
- Trial name
- NCT04610385
- Testing
- radical cystectomy with urinary diversion
- Volunteers
- 40 people
- Sponsor
- Assiut University
Bladder Cancer Requiring Cystectomy, Ileal Conduit
A Feasibility Randomized Trial Evaluating Early vs Late Stent Removal Following Radical Cystectomy and Ileal Conduit Formation for Bladder Cancer
Bladder cancer is the 4th most common cancer in men and 5th most common type of cancer in Canada. Urothelial cancer accounts for approximately 90% of malignancies.
- Conditions
- Bladder Cancer Requiring Cystectomy, Ileal Conduit, Urinary Diversion
- Trial name
- STENT-OPT (NCT06595446)
- Testing
- Early Stent removal, Late Stent removal
- Where
- Canada
- Volunteers
- 60 people
- Sponsor
- Western University, Canada
Bladder Cancer, Urinary Tract Infection
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
This is a single arm, interventional pilot study of using chlorhexidine irrigation intra-operatively and post-operatively among patients undergoing radical cystectomy with urinary diversion.
- Trial name
- NCT06689176
- Testing
- Irrisept® Antimicrobial Wound Lavage
- Where
- United States
- Volunteers
- 23 people
- Sponsor
- Icahn School of Medicine at Mount Sinai
Bladder Cancer
The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patients Undergoing Laparoscopic Ileal Conduit
This study aims to compare the effects of intrathecal morphine (ITM) and continuous epidural analgesia (CEA) on bowel function recovery after Bricker surgery.This study was a prospective, randomized controlled trial that included…
- Trial name
- NCT06688643
- Testing
- ITM group, EA group
- Where
- China
- Volunteers
- 58 people
- Sponsor
- Xiaguang Duan
Bladder Cancer, Entire Ileal Conduit
Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy
The process of enhancing the functional capacity of an individual before an operation to enable him or her to withstand the stress of surgery has been termed prehabilitation.
- Conditions
- Bladder Cancer, Entire Ileal Conduit, Urinary Bladder Cancer
- Trial name
- NCT01836978
- Testing
- Prehabilitation
- Where
- Canada
- Volunteers
- 70 people
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
Cystectomy, Bladder Cancer Requiring Cystectomy
Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
The aim of this trial is to test whether postoperative antibiotics targeted towards bacteria in the urine can reduce the risk of infection after surgical removal of the bladder (cystectomy) compared to a standardised antibiotic…
- Conditions
- Cystectomy, Bladder Cancer Requiring Cystectomy, Postoperative Infections, Antibiotic Prophylaxis
- Trial name
- REINFORCE (NCT06709196)
- Testing
- Pivmecillinam, Amoxicillin clavulanic acid, Amoxicillin
- Where
- 5 sites in Denmark
- Volunteers
- 248 people
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Parastomal Hernia
Prevention of Parastomal Hernia by Mesh Placement
Concurrent placement of a mesh during formation of ileal conduit will decrease the incidence of parastomal hernia and associated complications.
- Trial name
- NCT02404545
- Testing
- Ethicon Physiomesh
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- University of Miami
Bladder Carcinoma, Hernia
PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)
This randomized phase III trial studies how well biologic mesh works in preventing parastomal hernia in patients with bladder cancer who are undergoing radical cystectomy, or removal of the bladder, and ileal conduit diversion.
- Trial name
- NCT02439060
- Testing
- Acellular Cadaveric Dermal Matrix
- Where
- United States
- Volunteers
- 156 people
- Sponsor
- University of Southern California
Bladder Cancer, Hernia
Surgical Mesh in Radical Cystectomy to Prevent Parastomal Hernias
Radical cystectomy with ileal conduit urinary diversion serves as a foundational curative treatment strategy for selected patients afflicted with urothelial carcinoma of the bladder.
- Conditions
- Bladder Cancer, Hernia, Ileal Conduit
- Trial name
- NCT06032910
- Testing
- Surgical mesh
- Where
- Czechia
- Volunteers
- 25 people
- Sponsor
- Charles University, Czech Republic
Bladder Cancer, Patient Engagement
Recovery Support for Bladder Cancer Patients and Caregivers
For patients with certain types of bladder cancer, the removal of the bladder and the construction of an artificial bladder or reservoir are the only treatment options.
- Conditions
- Bladder Cancer, Patient Engagement, Patient Empowerment, Ileal Conduit
- Trial name
- NCT04055311
- Testing
- Cancer Resource Information Support (CRIS), Usual Care Enhanced
- Where
- 2 sites in United States
- Volunteers
- 174 people
- Sponsor
- Northwell Health
Bladder Cancer, Anastomosis; Complications
The Impact of Manual Versus Mechanical Intestinal Suturing on the Incidence of Postoperative Complications Following Cystectomy With Ileal Conduit
Impact of Manual Versus Mechanical Intestinal Suturing on the Incidence and Management of Postoperative Complications in Patients Undergoing Radical Cystectomy with Ileal Conduit.
- Conditions
- Bladder Cancer, Anastomosis; Complications, Ileus Paralytic
- Trial name
- CIMMIS (NCT06928220)
- Testing
- cystectomy with ileal conduit, using mechanical bowel anastomosis, cystectomy with ileal conduit, using manual bowel anastomosis
- Where
- Spain
- Volunteers
- 120 people
- Sponsor
- Fundacio Puigvert
Bladder Cancer, Muscle-Invasive Bladder Carcinoma
Robotic Radical Cystectomy Outcomes
Currently, in the treatment of bladder cancer the use of robotics has entered in clinical practice, therefor robotic radical cystectomy with or without reconstruction is offered to patients during counseling procedures, if deemed…
- Conditions
- Bladder Cancer, Muscle-Invasive Bladder Carcinoma, Oncology, Recurrence
- Trial name
- NCT04900558
- Testing
- Radical Cystectomy
- Where
- Italy
- Volunteers
- 500 people
- Sponsor
- University of Florence
Bladder Cancer, Muscle-Invasive Bladder Carcinoma
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Subjects will be randomized into 2 groups (stent or no stent) prior to radical cystectomy with ileal conduit urinary diversion (RCIC). They will follow the standard of care and be enrolled in the study for 12 months post-op.
- Conditions
- Bladder Cancer, Muscle-Invasive Bladder Carcinoma, Urothelial Carcinoma, Pelvic Malignancy
- Trial name
- NCT07234968
- Testing
- Ureteral Stent Placement, No Ureteral Stent, Indocyanine Green with Fluorescence Imaging
- Where
- 2 sites in United States
- Volunteers
- 70 people
- Sponsor
- Thomas Jefferson University
Muscle-Invasive Bladder Carcinoma, Radical Cystectomy
Prophylactic Antibiotics in Cystectomy With Diversion
Using a randomized 2 arm design, this study is being conducted to test for non-inferiority of no prophylactic antibiotic therapy versus the prophylactic oral antibiotic, nitrofurantoin, through comparison of rates of…
- Conditions
- Muscle-Invasive Bladder Carcinoma, Radical Cystectomy, Ileal Conduit, Neobladder Diversion
- Trial name
- NCT06190197
- Testing
- Prophylactic antibiotics postoperatively.
- Where
- United States
- Volunteers
- 120 people
- Sponsor
- University of Minnesota
Ileal Conduit, Parastomal Hernia
Role of Mesh Stoma Reinforcement Technique (MSRT) in Prevention of Parastomal Hernia After Ileal Conduit Urinary Diversion
The aim of this clinical trial is to investigate the safety and efficacy of prophylactic mesh on prevention of parastomal hernia(PSH) after ileal conduit urinary diversion (IC) in a randomized controlled fashion.
- Trial name
- NCT02387333
- Testing
- Polypropylene Mesh Stoma reinforcement technique with ileal conduit urinary diversion, Ileal conduit urinary diversion
- Where
- Egypt
- Volunteers
- 40 people
- Sponsor
- Mansoura University